Objective: To assess the association between nonsyndromic (NS) cleft lip with or without cleft palate (CL(P)) and single-nucleotide polymorphisms (SNPs) within the CRISPLD2 gene (cysteine-rich secretory protein LCCL domain containing 2).
Craniofacial anomalies, and in particular oral-facial clefts including cleft lip (CL) and cleft palate (CP), are major human structural birth defects with a worldwide frequency of 1 in 700 live births and substantial clinical impact. The possible etiologies are many, including singlegene disorders, chromosome aberrations, exposure to teratogens, and sporadic conditions of unknown cause (Murray, 2002) . Oral-facial clefts can be further classified as nonsyndromic (NS; i.e., isolated) or syndromic based on the presence of other structural anomalies. Approximately 30% of all clefts are associated with one of more than 400 described syndromes (Gorlin et al., 2001) , while the remaining 70% are isolated defects. It is generally accepted that CL with or without CP (CL(P)) and cleft palate alone (CP) are developmentally distinct phenotypes. CL(P) is more common, affecting 1 to 2 in 1000 births and presenting considerable differences in prevalence, with Native Americans and Asians showing the highest rate and Africans the lowest. CP is less common, with a prevalence of approximately 1 in 1500 to 2000 births in Caucasians, which is less variable among different ethnic backgrounds (Forrester and Merz, 2004) .
The nature of the genetic contribution to the etiology of NS CL(P) and CP is still a subject for discussion and investigation. Analyses of familial recurrence risk patterns in CL(P) have estimated that 3 to 14 genes interacting multiplicatively may be involved, indicating that CL(P) is a heterogeneous disorder (Schliekelman and Slatkin, 2002) . Nevertheless, despite the evidence for a genetic role in the etiology of CL(P) and CP, environmental factors such as smoking and maternal nutrition are also thought to influence this structural birth defect, possibly in an interactive manner (Maestri et al., 1997; Wyszynski et al., 1997) . Therefore, etiological heterogeneity has probably been a major confounding factor for identifying clefting susceptibility loci.
Recent advances in high-throughput genotyping technologies and powerful statistical approaches have accelerated the discovery of loci conferring susceptibility for complex diseases through the use of genome scans (Altmuller et al., 2001) . The first CL(P) scan was conducted with 92 British sib pairs and identified nine regions with suggestive results, including a region on chromosome 16q (Prescott et al., 2000; Prescott et al., 2001) . Other genomic scans followed, and the region of 16q21-24 reached genome-wide statistical significance for linkage with CL(P) in multiple studies (Field et al., 2004; Marazita et al., 2004a; Marazita et al., 2004b; Marazita et al., 2009) .
CRISPLD2 (cysteine-rich secretory protein containing LCCL domain 2) gene is located on chromosome 16q24.1 and has been recently associated with nonsyndromic CL(P) in U.S. Caucasian and Hispanic populations (Chiquet et al., 2007) . Moreover, the authors detected CRISPLD2 expression in the mandible, palate, and nasopharynx regions during craniofacial development at E13.5-E17.5 and have suggested CRISPLD2 as a novel candidate gene for the etiology of NS CL(P). Although the function of CRISPLD2 remains to be elucidated, its structure featuring the presence of a LCCL (Limulus factor C, Coch-5b2 and Lgl1) domain has been suggested to play a structural or immunologic role or even be involved in cell motility (Liepinsh et al., 2001; Nagai et al., 2007) . Interestingly, cell motility is required for effective cell migration, which, together with apoptosis, accounts for the cellular mechanism responsible for the disappearance of medial edge epithelia cells prior to palatal fusion (Chai and Maxson, 2006) .
Given the observed population differences in CL(P) and CP birth prevalences and other characteristics, it is of interest to expand studies of orofacial cleft etiology to diverse populations. In this study, we performed association studies with CRISPLD2 and NS CL(P) and NS CP in a large cohort sample consisting of distinct populations from North America, South America, Asia, and Northern and Eastern Europe.
SUBJECTS AND METHODS

Subjects
The study population consisted of a total of 5826 genotyped individuals from distinct population sets. Included were 1023 multiplex families from the Philippines, Guatemala, Europe (Spain, Hungary, Turkey), and the United States (Iowa, Pennsylvania, Missouri, and Texas). In addition, there were 308 nuclear trios, 84 from China plus 224 from Argentina, Brazil, and Chile, ascertained through ECLAMC (Latin American Collaborative Study of Congenital Malformations). There were also 610 unrelated individuals (328 NS CL(P) cases and 282 controls with no known family history of clefting) of Caucasian ethnicity from Brazil. Table 1 summarizes all of the populations, families, and individuals. With the exception of ECLAMC, which is a hospital-based birth defects registry study, all families were ascertained by recruitment, either from community-based ascertainment (the Philippines) or through clinical facility-based ascertainment (remainder of sites).
All cases had NS CL, CP, or CL with CP (CLP). CL and CLP combined comprise CL(P). Informed consent was obtained from each study subject after approval by the appropriate institutional review boards in the United States (University of Pittsburgh, Pittsburgh, PA; University of Iowa, IA; Washington University, St. Louis, MO; University of Texas, Houston, TX) and each participating international site (details provided on request).
Blood or saliva samples were collected to obtain genomic DNA. Procedures for DNA extraction were performed according to standard protocols.
Genotyping
Four single-nucleotide polymorphisms (SNPs) within the CRISPLD2 gene domain previously shown to be associated with CL(P) (Chiquet et al., 2007) were genotyped using Taqman chemistry on an automatic sequence-detection instrument (ABI Prism 7900HT, Applied Biosystems, Foster City, CA). Assays and reagents were supplied by Applied Biosystems. Details of the studied polymorphisms are presented in Table 2 . Further, Table 3 presents the allelic and genotypic frequencies by population subgroups, plus the results of tests of Hardy Weinberg equilibrium (HWE).
Statistical Analysis
Families were analyzed separately according to population and then in subgroups. We combined all the North American Caucasian samples from Pittsburgh, St. Louis, Iowa, and Texas to form a North American group. The European Caucasians (Turkey, Spain, and Hungary) were added to the North American group to form an overall Caucasian group. The data from Guatemala and ECLAMC formed the South American group. Note that the Guatemalans and the registry participants from ECLAMC are of European (Spain and Portugal) extractions as well as a mixture of Amer-Indians and Africans. A Hispanic group was formed with the self-reported Hispanics from Texas and the South American group to address any inquiries as to ethnic environmental considerations.
For some analyses, the families were divided into the following nonoverlapping subsets: CL 5 families in which all affecteds had CL only; CLP 5 all affecteds had CL plus CP; CLCLP 5 at least one affected with CL plus at least one with CLP; CP 5 at least one affected with CP alone. Another grouping was designated CL(P) and consisted of the combination of the CL, CLP, and CLCLP subsets.
The properties of the SNPs were assessed in the proband trios using Haploview (Barrett et al., 2005) , that is, to assess LD between the SNPs, to test for HWE, and to estimate the minor allele frequencies (MAF).
The association between clefting and SNPs in the CRISPLD2 gene was determined by transmission disequilibrium tests (TDTs) in the family data, as implemented in the Family Based Association Test, version 1.7.3 Rabinowitz and Laird, 2000; Horvath et al., 2001) . Allelic, genotypic, and haplotype TDT analyses were performed with the empirical analysis option to adjust for families with multiple parent-child trios. Parent of origin effects were assessed in the proband trios using PLINK (Purcell et al., 2007) . For the Brazilian case-control sample, allelic/genotypic associations were assessed with chi-square tests as implemented in SAS (version 9.1.3).
Nominal p values are reported. With a Bonferroni correction for multiple testing (considering the number of CLCLP 5 at least one affected member with CL and one with CLP; CP 5 at least one affected member with CP. The analysis group was CL(P) 5 CL+CLP+CLCLP.
{ Brazilian study subjects were unrelated cases (CL 5 4, CLP 5 324) and controls (i.e., not families).
{ Families originally reported (Chiquet et al., 2007) . variables and tests performed), p values less than .0006 (.05/ 80) would be considered statistically significant.
RESULTS
Preliminary Analyses
Pairwise linkage disequilibrium (D9 values) between the four SNPs were calculated for each population using the Graphical Overview of Linkage Disequilibrium (GOLD) program (Abecasis and Cookson, 2000) and ranged from 0.02 to 0.23; thus, it is likely that very little redundant information was obtained from the data (data not shown). Table 3 presents the allelic and genotypic frequencies and the p values from the tests of HWE by each subpopulation. There was no evidence of deviation from HWE for any of the SNP/population group combinations, except for SNP rs4783099 in the North American Caucasian and ALL Caucasian groups.
Association Analyses
The results of case-control and family-based allelic association analyses stratified by population are summarized in Table 4 . None of these results reached formal Bonferroni-adjusted significance (i.e., p value ,.0006); however, results in 2 SNPs (rs1546124 and rs8061351) were nominally significant (p , .05) for the Brazilian casecontrol sample (Caucasian), the U.S. Caucasians, and suggestive (.5 # p , .10) in Turkey, in addition to the original results from Texas (Chiquet et al., 2007) . Interestingly, the results from Asia and the Latin American admixed populations (Guatemala and ECLAMC) were not significant for any SNP. Table 5 shows the results from the TDT allelic association analyses by cleft family subgroups. There are some suggestions in the results that the CLP subgroup (i.e., families in which all affecteds have CL plus CP) have the greatest statistical significance in the Caucasian populations for SNP rs1546124. Of interest, in the Asian subgroup, there was a suggestive result in the CP family subgroup (p 5 .003); however, the sample size was very small (15 informative families out of 37 total CP families). The haplotype TDT association results are not presented in detail because in no case did the significance levels improve over the individual SNP results. Similarly, there was no significant evidence of parent-of-origin effects for any SNP; therefore, those results are not presented in detail. Table 6 presents the Brazilian case-control results for both allelic and genotypic association for all cases and for subgroups of the cases based on cleft laterality and completeness (Letra et al., 2007) . Again, no formal signifi- cance was seen, but results for three of the SNPs (rs1546124, rs8061351, and rs2326398) were nominally significant or suggestive. The most significant results were with SNP rs8061351 for incomplete clefts (allelic p value 5 .009, genotypic 5 .004), for unilateral incomplete clefts (genotypic p value 5 .003), and with SNP rs2326398 for bilateral (allelic p value 5 .004) and bilateral complete (allelic p value 5 .007).
Prediction of SNP Functionality
To verify if the synonymous mutation C471T (rs8061351) in exon 4 of the CRISPLD2 gene associated with incomplete cleft lip/palate in the Brazilian individuals and in the Hispanic families from Texas (Table 4 ) could disrupt DNA-binding sites and further affect CRISPLD2 protein expression, two transcription binding site prediction methods, FASTSNP and AliBaba 2.1, were used (Matys et al., 2006; Yuan et al., 2006) . FASTSNP identified that the C allele, overrepresented in cases with cleft lip/ palate, affects splicing regulation by altering exonic splicing enhancer motifs; FASTSNP attributes a low-medium risk for this allele. Further, AliBaba 2.1 identified a Sp1 binding site with either C or T alleles; however, the C allele also harbored a binding site for transcription factor AP-2 alpha.
DISCUSSION
The current study sought to replicate the original study (Chiquet et al., 2007) that identified the CRISPLD2 (cysteine-rich secretory protein containing LCCL domain 2) gene as a novel candidate gene for NS CL(P). CRISPLD2 is located on chromosome 16q24.1, spans approximately 8.95 kb, and contains 14 exons coding for a 497 amino acid polypeptide. The exact function of this gene { Cleft family subgroups: CL 5 those pedigrees in which all affected members have CL only; CLP 5 affected members all have CL with CP; CLCLP 5 at least one affected member with CL and one with CLP; CL(P)5 cleft with or without cleft palate families (i.e., a combination of the CL, CLP, CLCLP subgroups); CP 5 at least one affected member with CP.
{ p value (allele) 5 TDT p value and associated allele. p values in bold italics reach nominal significance (i.e., p value ,.05); values in bold are suggestive (.05 , p value , .10). 1 n 5 the number of informative families in the TDT (see Table 1 for the number of families in each cleft family subgroup).
is not yet known; nevertheless, in situ hybridization of mouse tissues showed CRISPLD2 expression in the nasopharynx and oropharynx at E13.5, the mandible at E14.5, and the palate and cartilage primordia of the nasal septum at E17.5 (Chiquet et al., 2007) . We investigated the SNPs associated in the original study (Chiquet et al., 2007) in a large NS CL(P) and CP cohort consisting of 12 distinct populations (see Table 1 ). Although not reaching formal Bonferroni-adjusted significance, several results were suggestive for CL(P) in the Caucasian populations but interestingly not in the Asian or admixed populations, while the Asian populations had suggestive results for CP. Of note, statistical significance was increased when cases were stratified based on cleft phenotypes.
One polymorphism (rs1546124), located at the 59 UTR of the CRISPLD2 gene, showed significant altered transmission in the Caucasian cohort in the original study (Chiquet et al., 2007) and was the only SNP significantly associated with CL(P) in that study. In the current study, a synonymous mutation in exon 4 (C471T, rs8061351) showed association with the case-control cohort from Brazil and was also shown to be associated with the Hispanic cohort in the original study (Chiquet et al., 2007) . Furthermore, our results also suggest that SNP rs1546124 may have a stronger effect on individuals of Caucasian ethnicity, whereas SNP rs8061351 seems to have a stronger effect on individuals of Hispanic or South American origin. A possible explanation for this discrepancy is that distinct populations may have different risk alleles.
Recently, a study of 31 SNPs in 12 candidate genes including CRISPLD2 was conducted in an Irish study, comprising 509 CL(P) and 383 CP case trios and 926 population-based controls and including three of the four SNPs analyzed in the current study (Carter et al., 2010) . This study population is most comparable to the ALL Caucasian subgroup in the current study. Notably, for the three SNPs in common between the studies (rs1546124, rs8061351, rs4783099), the minor alleles (G, C, T, respectively) and MAF values in the current study (see Table 3 ) were comparable with those presented in Table 2 of the Irish study (Carter et al., 2010) . However, the Irish study found no statistically significant association with any of the three SNPs in common, nor with three additional CRISPLD2 SNPs assessed only in the Irish study. One of the SNPs in common, rs1546124, showed suggestive association in the current study of Caucasians. These differing results could be in part because the study designs differed. Our study population was enriched in multiplex families since most were ascertained as part of a linkage study (Marazita et al., 2009 ), whereas 7.5% of the Irish study cases had a positive family history of orofacial clefts. Notably, the region of 16q21-24 reached genome-wide statistical significance for linkage with CL(P) in multiple studies (Field et al., 2004; Marazita et al., 2004a; Marazita et al., 2004b; Marazita et al., 2009) , consistent with an hypothesis that the CRISPLD2 relationship with CL(P) may be the most important in familial cases.
Of note, several chromosomal abnormalities involving chromosome 16 have been described that include clefting as part of the clinical phenotype. Duplications of 16p12-13 (Brewer et al., 1999) , as well as trisomy and translocations of chromosome 16 (Ducos et al., 2004) have been associated with cleft palate. In addition, one marker at approximately 7 kb from the MMP25 gene on chromosome 16p13.3 has shown association with NS CL(P) (Blanton et al., 2004) . More specifically, the region between 16q21-24 has been identified in genomic scans as harboring susceptibility genes for CL(P) (Prescott et al., 2000; Field et al., 2004; Marazita et al., 2004a; Marazita et al., 2004b; Marazita et al., 2009 ). Further, other investigators have also demonstrated the presence of CP with mutations in genes located in or around 16q21-24. Hecht et al. (1991) observed a correlation between cleft palate and variations { Phenotype subgroups: groupings of the cleft cases; TOTAL 5 all cases, unilateral and bilateral refer to laterality, complete and incomplete refer to the completeness of the cleft; Uni+Comp 5 unilateral and complete; Uni+InComp 5 unilateral and incomplete; Bi+Comp 5 bilateral and complete; Bi+InComp 5 bilateral and incomplete { n 5 number or cases or controls. Note that some of the phenotype subgroup numbers do not add up to the TOTAL because some of the cases did not have laterality or completeness information.
1 In parentheses is the associated allele or genotype for those SNPs in which one or more p value ,0.10.
at 16q22.1, while mutations in the FOXC2 gene located at 16q24.3 have been shown to cause distichiasis, lymphedema, and CP (Bahuau et al., 2002) . Although the function of CRISPLD2 is unknown, effects of mutations in its structure may be predicted. It has been proposed that SNP rs1546124, a C/G polymorphism located at the 59 UTR, may have a functional effect on CRISPLD2 transcription by the presence of an Sp1 binding site whenever a G allele is present (Nagai et al., 2007) . We further verified that SNP rs8061351, which denotes a C471T silent mutation with both nucleotides coding for a proline, also implies differences in functionality depending on the allele present. We observed that the C allele, which is overrepresented in the cases with clefts of the lip and of the primary palate, alters splicing regulation by diminishing exonic splicing enhancer motifs. Moreover, the C allele also creates a binding site for transcription factor AP-2 alpha, involved in craniofacial development and recently suggested as an important regulatory element for IRF6 expression and, in turn, for the occurrence of CL(P). Nevertheless, although synonymous changes should not affect gene expression or the final protein product, they may lead to the synthesis of a protein product with the same amino acid sequence but different structural and functional properties and thus should not be neglected in determining the risk of development of various diseases (Komar, 2007a (Komar, , 2007b .
Whether variants in the CRISPLD2 gene are causal agents for CL(P) is yet to be confirmed. So far, the only biological evidence for a possible role in palate development is the expression of CRISPLD2 at E17.5 in mice, a time point that does not seem to be critical since the process of palatogenesis is known to be complete by E15 (Dudas et al., 2007) . Nonetheless, the associations observed in this and other genetic studies (Blanton et al., 2004; Chiquet et al., 2007; Marazita et al., 2009) and the observations on SNP functionality warrant further investigations to clarify the role for CRISPLD2 in NS CL(P) and CP suggested by our results.
CONCLUSIONS
This study further demonstrates that variants in the CRISPLD2 gene may be involved in the pathogenic mechanism of NS CL(P), using a much larger sample size and additional ethnicities beyond the original publication (Chiquet et al., 2007) . Nevertheless, the exact biological functions and the contribution of CRISPLD2 to the clefting phenotype are still to be clarified.
